(2S,4s)-Fmoc-4-fluoropyrrolidine-2-carboxylic acid is a non-proteinogenic amino acid derivative featuring a fluorinated pyrrolidine ring. The compound contains a carboxylic acid group and a fluorenylmethyloxycarbonyl (Fmoc) protecting group on the nitrogen atom. This specific stereochemistry (2S,4s) is crucial for its application in peptide synthesis. This building block is primarily used in solid-phase peptide synthesis (SPPS) as a protected amino acid. The fluorine atom on the pyrrolidine ring serves as a key structural modification, often introduced to enhance the metabolic stability, alter the conformational properties, or modulate the biological activity of the resulting peptides. It is a valuable intermediate for the synthesis of peptide-based drug candidates, particularly in the development of protease inhibitors and other therapeutic peptides where rigidity and resistance to enzymatic degradation are desired. The Fmoc group is standard for Fmoc/tBu SPPS strategies, allowing for orthogonal deprotection under mild basic conditions. Its use enables the controlled assembly of complex peptides containing this fluorinated proline analog, which is of significant interest in medicinal chemistry and chemical biology research.